Market Overview:
The global biopharmaceutical market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for biologics, and technological advancements in the field of biopharmaceuticals. The monoclonal antibodies segment is expected to dominate the global biopharmaceutical market during the forecast period. This segment is projected to grow at a CAGR of 11.5% from 2018 to 2030 due to the increasing demand for monoclonal antibodies for various applications such as tumor diagnosis and treatment, diabetes management, and cardiovascular diseases treatment. The Asia Pacific region is projected to be fastest-growing region during the forecast period owingto factors such as growing population, rising income levels, and expanding healthcare infrastructure in countries such as China.
Product Definition:
A biopharmaceutical, also known as a biologic medication or biological medication, is a pharmaceutical drug that is biologically derived from natural sources. Biopharmaceuticals are usually recombinant proteins produced by bacterial fermentation, but they can also be monoclonal antibodies, vaccines or blood products.
Monoclonal Antibodies:
Monoclonal antibodies are antibody molecules, which are manufactured by the human body. There is a wide range of monoclonal antibodies available in the market, which caters to various applications in biopharmaceuticals and medical industries. Some of these products include trastuzumab (Herceptin), rituximab (Rituxan), daclizumab (Zenapax), and others.
Interferon:
Interferon is a type of protein hormone that modulates the immune system. It is produced by cells in response to viral infection, bacterial disease, or exposure to certain chemicals. Interferons are used as medicines for the treatment of multiple sclerosis and cancer. They are also being studied for use in treating HIV/AIDS and hepatitis C virus (HCV).
Application Insights:
The tumor segment dominated the global biopharmaceutical market in 2017 and is expected to witness significant growth over the forecast period. Increasing cancer prevalence coupled with rising demand for innovative therapeutics is anticipated to drive this application segment.
Diabetes held a substantial share of the global market in 2017 owing to an increase in diabetes-related disorders, such as type 1 and type 2, which require regular monitoring and management by using insulin or other oral antidiabetic drugs (OADs). Moreover, increasing awareness about these applications among individuals suffering from diabetes is expected to fuel product demand over the forecast period.
Cardiovascular diseases are one of the leading causes of death globally due largely to an increase in lifestyle-related cardiovascular diseases along with other non-communicable diseases that have become prevalent during recent years.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biopharmaceutical manufacturers and CROs has fueled the growth of this regional market. Moreover, increasing R&D investment by companies and rising awareness about advanced therapeutics are some other factors contributing to its growth. Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing focus on drug development activities by several biopharmaceutical companies as well as government support for innovation in India, China, South Korea & Taiwan (ISCID) region especially Japan is driving this regional market. In addition, favorable regulatory policies such as “One-China†policy implemented by Beijing which favors free trade agreement between China & Hong Kong SAR has boosted investments from foreign players particularly U.S.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and heart diseases which require long-term treatment with biopharmaceuticals.
- Growing demand for innovative and targeted therapies to treat various life-threatening diseases.
- Rising public and private investments in R&D of novel biopharmaceuticals products.
- Technological advancements in the field of biotechnology that are helping to develop better and more effective drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biopharmaceutical Market Research Report
By Type
Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Other
By Application
Tumor, Diabetes, Cardiovascular, Hemophilia, Other
By Companies
Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Biopharmaceutical Market Report Segments:
The global Biopharmaceutical market is segmented on the basis of:
Types
Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tumor, Diabetes, Cardiovascular, Hemophilia, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
Highlights of The Biopharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Other
- By Application:
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biopharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A biopharmaceutical is a drug or other therapeutic agent that is derived from living organisms.
Some of the key players operating in the biopharmaceutical market are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck.
The biopharmaceutical market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopharmaceutical Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Biopharmaceutical Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Biopharmaceutical Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Biopharmaceutical Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Biopharmaceutical Market Size & Forecast, 2018-2028 4.5.1 Biopharmaceutical Market Size and Y-o-Y Growth 4.5.2 Biopharmaceutical Market Absolute $ Opportunity
Chapter 5 Global Biopharmaceutical Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biopharmaceutical Market Size Forecast by Type
5.2.1 Monoclonal Antibodies
5.2.2 Interferon
5.2.3 Erythropoietin
5.2.4 Insulin
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biopharmaceutical Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biopharmaceutical Market Size Forecast by Applications
6.2.1 Tumor
6.2.2 Diabetes
6.2.3 Cardiovascular
6.2.4 Hemophilia
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biopharmaceutical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biopharmaceutical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biopharmaceutical Analysis and Forecast
9.1 Introduction
9.2 North America Biopharmaceutical Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biopharmaceutical Market Size Forecast by Type
9.6.1 Monoclonal Antibodies
9.6.2 Interferon
9.6.3 Erythropoietin
9.6.4 Insulin
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biopharmaceutical Market Size Forecast by Applications
9.10.1 Tumor
9.10.2 Diabetes
9.10.3 Cardiovascular
9.10.4 Hemophilia
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biopharmaceutical Analysis and Forecast
10.1 Introduction
10.2 Europe Biopharmaceutical Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biopharmaceutical Market Size Forecast by Type
10.6.1 Monoclonal Antibodies
10.6.2 Interferon
10.6.3 Erythropoietin
10.6.4 Insulin
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biopharmaceutical Market Size Forecast by Applications
10.10.1 Tumor
10.10.2 Diabetes
10.10.3 Cardiovascular
10.10.4 Hemophilia
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biopharmaceutical Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biopharmaceutical Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biopharmaceutical Market Size Forecast by Type
11.6.1 Monoclonal Antibodies
11.6.2 Interferon
11.6.3 Erythropoietin
11.6.4 Insulin
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biopharmaceutical Market Size Forecast by Applications
11.10.1 Tumor
11.10.2 Diabetes
11.10.3 Cardiovascular
11.10.4 Hemophilia
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biopharmaceutical Analysis and Forecast
12.1 Introduction
12.2 Latin America Biopharmaceutical Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biopharmaceutical Market Size Forecast by Type
12.6.1 Monoclonal Antibodies
12.6.2 Interferon
12.6.3 Erythropoietin
12.6.4 Insulin
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biopharmaceutical Market Size Forecast by Applications
12.10.1 Tumor
12.10.2 Diabetes
12.10.3 Cardiovascular
12.10.4 Hemophilia
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biopharmaceutical Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biopharmaceutical Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biopharmaceutical Market Size Forecast by Type
13.6.1 Monoclonal Antibodies
13.6.2 Interferon
13.6.3 Erythropoietin
13.6.4 Insulin
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biopharmaceutical Market Size Forecast by Applications
13.10.1 Tumor
13.10.2 Diabetes
13.10.3 Cardiovascular
13.10.4 Hemophilia
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biopharmaceutical Market: Competitive Dashboard
14.2 Global Biopharmaceutical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Amgen
14.3.3 AbbVie
14.3.4 Sanofi-Aventis
14.3.5 Johnson & Johnson
14.3.6 Pfizer
14.3.7 Novo Nordisk
14.3.8 Eli Lilly
14.3.9 Novartis
14.3.10 Merck